Psoriasis: Clinical Response to Systemic Medications
2024 · Higher is better
Clinician group · Grand Junction, CO
2024 · Higher is better
2024 · Higher is better
CMS files are dated Sep 10, 2026 to Oct 15, 2026·Model ml-4·Coverage and freshness
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Psoriasis: Clinical Response to Systemic Medications, 2024. Higher is better. It does not predict your own result.
Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient- reported disease activity levels.
It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment.
Published stratum: overall.
Exact public stratum retained; no pooling with other strata.
2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_410_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Melanoma: – Appropriate Surgical Margins, 2024. Higher is better.
Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology- Melanoma (NCCN Guideline).
Published stratum: overall.
Exact public stratum retained; no pooling with other strata.
2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: CMSgov/qpp-measures-data 2024.
Published eligible intermediateOutcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Missing values stay missing. A grey value means the publisher reported no figure, often because there were too few cases. It does not mean the result is bad.
The reviewed data do not publish this result.
Loading…
data.cms.gov · released 10 Sep 2026
data.cms.gov · released 12 Nov 2026
Official public federal aggregate data; cite CMS, no endorsement. Clinical periods are separate from publisher release and operational fetch dates. No government endorsement.
Missing evidence is not zero and does not mean poor care. Source list · Coverage and freshness